Neogenomics Inc
NEO5.445USD
+0.285+5.52%
Market hours （ET）Quotes delayed by 15 min
700.67MMarket Cap
LossP/E TTM
More Details of Neogenomics Inc Company
NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. The Advanced Diagnostics segment consist of clinical trials and research, validation laboratory services, and informatics. Its Advanced Diagnostics customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials.
Company Info
Ticker SymbolNEO
Company nameNeogenomics Inc
IPO dateDec 10, 2012
CEOMr. Antony P. Zook
Number of employees2200
Security typeOrdinary Share
Fiscal year-endDec 10
Address9490 Neogenomics Way
CityFORT MYERS
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code33912
Phone12397680600
Websitehttps://neogenomics.com/
Ticker SymbolNEO
IPO dateDec 10, 2012
CEOMr. Antony P. Zook
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
166.66K
+21.81%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
108.28K
+19.26%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
52.34K
+30.57%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
28.10K
+77.33%
Ms. Elizabeth Floegel
Ms. Elizabeth Floegel
Independent Director
Independent Director
23.59K
+108.10%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
7.16K
--
Ms. Marjorie C. Green
Ms. Marjorie C. Green
Independent Director
Independent Director
--
--
Mr. David B. Perez
Mr. David B. Perez
Independent Director
Independent Director
--
--
Ms. Alicia Olivo
Ms. Alicia Olivo
Executive Vice President, General Counsel & Business Development
Executive Vice President, General Counsel & Business Development
--
--
Mr. Michael A. Kelly
Mr. Michael A. Kelly
Lead Independent Director
Lead Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
166.66K
+21.81%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
108.28K
+19.26%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
52.34K
+30.57%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
28.10K
+77.33%
Ms. Elizabeth Floegel
Ms. Elizabeth Floegel
Independent Director
Independent Director
23.59K
+108.10%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
7.16K
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Clinical Services-Client direct billing
122.04M
72.63%
Clinical Services-Commercial Insurance
24.86M
14.79%
Clinical Services-Medicare and Medicaid
21.10M
12.56%
Clinical Services-Self-Pay
39.00K
0.02%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Clinical Services-Client direct billing
122.04M
72.63%
Clinical Services-Commercial Insurance
24.86M
14.79%
Clinical Services-Medicare and Medicaid
21.10M
12.56%
Clinical Services-Self-Pay
39.00K
0.02%
Shareholding Stats
Updated: Wed, May 14
Updated: Wed, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.16%
The Vanguard Group, Inc.
11.01%
First Light Asset Management, LLC
4.68%
Janus Henderson Investors
4.44%
State Street Global Advisors (US)
3.94%
Other
61.77%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.16%
The Vanguard Group, Inc.
11.01%
First Light Asset Management, LLC
4.68%
Janus Henderson Investors
4.44%
State Street Global Advisors (US)
3.94%
Other
61.77%
Shareholder Types
Shareholders
Proportion
Investment Advisor
50.11%
Investment Advisor/Hedge Fund
37.15%
Hedge Fund
7.37%
Research Firm
1.52%
Individual Investor
1.19%
Pension Fund
1.13%
Bank and Trust
0.58%
Sovereign Wealth Fund
0.39%
Insurance Company
0.04%
Other
0.51%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
569
127.92M
99.03%
-12.74M
2025Q1
596
131.44M
102.13%
-4.71M
2024Q4
585
127.59M
99.32%
-7.82M
2024Q3
589
129.38M
100.96%
-8.76M
2024Q2
597
131.21M
102.74%
-9.36M
2024Q1
633
132.83M
104.04%
-13.13M
2023Q4
672
130.90M
102.70%
-12.18M
2023Q3
691
124.98M
98.00%
-16.78M
2023Q2
691
121.76M
95.45%
-23.63M
2023Q1
704
120.14M
94.21%
-27.80M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
18.29M
14.21%
-356.84K
-1.91%
Mar 31, 2025
The Vanguard Group, Inc.
14.23M
11.06%
+17.23K
+0.12%
Mar 31, 2025
First Light Asset Management, LLC
6.04M
4.7%
+2.88M
+90.77%
Mar 31, 2025
Janus Henderson Investors
5.74M
4.46%
-424.04K
-6.88%
Mar 31, 2025
State Street Global Advisors (US)
5.09M
3.95%
-109.12K
-2.10%
Mar 31, 2025
Greenhouse Funds LLLP
4.71M
3.66%
+6.43K
+0.14%
Mar 31, 2025
Macquarie Investment Management
4.68M
3.63%
+864.39K
+22.67%
Mar 31, 2025
Schroder Investment Management North America Inc.
4.31M
3.35%
+509.99K
+13.42%
Mar 31, 2025
Brown Advisory
3.87M
3.01%
-2.28M
-37.10%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
3.85M
2.99%
+408.27K
+11.88%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
SPDR S&P Health Care Services ETF
1.78%
Invesco S&P SmallCap Health Care ETF
0.67%
WisdomTree BioRevolution Fund
0.63%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.34%
iShares U.S. Healthcare Providers ETF
0.15%
Inspire Small/Mid Cap ESG ETF
0.15%
Federated Hermes MDT Small Cap Core ETF
0.12%
Nuveen ESG Small-Cap ETF
0.09%
iShares ESG Select Screened S&P Small-Cap ETF
0.08%
SPDR S&P 600 Small Cap Value ETF
0.08%
View more
SPDR S&P Health Care Services ETF
Proportion1.78%
Invesco S&P SmallCap Health Care ETF
Proportion0.67%
WisdomTree BioRevolution Fund
Proportion0.63%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion0.34%
iShares U.S. Healthcare Providers ETF
Proportion0.15%
Inspire Small/Mid Cap ESG ETF
Proportion0.15%
Federated Hermes MDT Small Cap Core ETF
Proportion0.12%
Nuveen ESG Small-Cap ETF
Proportion0.09%
iShares ESG Select Screened S&P Small-Cap ETF
Proportion0.08%
SPDR S&P 600 Small Cap Value ETF
Proportion0.08%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
